Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | Curated by TDR Targets | References |
Homo sapiens | dipeptidyl-peptidase 4 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Raf kinase | 0.1281 | 0.9637 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0383 | 0.2587 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0383 | 0.2587 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1327 | 1 | 1 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0209 | 0.1221 | 0.1227 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0383 | 0.2587 | 0.5 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.007 | 0.013 | 0.5 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.007 | 0.013 | 0.5 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.007 | 0.013 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0383 | 0.2587 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.007 | 0.013 | 0.0135 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0383 | 0.2587 | 0.5 |
Loa Loa (eye worm) | TKL/RAF/RAF protein kinase | 0.0752 | 0.5487 | 0.5515 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0209 | 0.1221 | 0.1105 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.007 | 0.013 | 0.5 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.007 | 0.013 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0209 | 0.1221 | 0.1267 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0383 | 0.2587 | 0.5 |
Loa Loa (eye worm) | raf kinase | 0.132 | 0.9949 | 1 |
Echinococcus multilocularis | raf serine:threonine protein kinase | 0.1327 | 1 | 1 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0209 | 0.1221 | 0.5 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0383 | 0.2587 | 0.5 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0209 | 0.1221 | 0.1105 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0209 | 0.1221 | 0.1105 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0383 | 0.2587 | 0.5 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.007 | 0.013 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.6 nM | Inhibition of human DPP4 | ChEMBL. | 17293118 |
IC50 (binding) | = 5.6 nM | Inhibition of human DPP4 | ChEMBL. | 17293118 |
Inhibition (functional) | 0 | Ex vivo inhibition of DPP4 in cynomolgus monkey at 1 mg/kg, po after 12 hrs | ChEMBL. | 17293118 |
Inhibition (functional) | = 16 % | Ex vivo inhibition of DPP4 in beagle dog at 1 mg/kg, po after 12 hrs | ChEMBL. | 17293118 |
Inhibition (binding) | = 71 % | Ex vivo inhibition of DPP4 in Sprague-Dawley rats plasma at 1 mg/kg, po after 12 hrs | ChEMBL. | 17293118 |
Inhibition (binding) | = 71 % | Ex vivo inhibition of DPP4 in Sprague-Dawley rats plasma at 1 mg/kg, po after 12 hrs | ChEMBL. | 17293118 |
Inhibition (binding) | = 77 % | Ex vivo inhibition of DPP4 in Sprague-Dawley rats plasma at 1 mg/kg, po after 10 hrs | ChEMBL. | 17293118 |
Inhibition (binding) | = 77 % | Ex vivo inhibition of DPP4 in Sprague-Dawley rats plasma at 1 mg/kg, po after 10 hrs | ChEMBL. | 17293118 |
Inhibition (binding) | = 86 % | Ex vivo inhibition of DPP4 in Sprague-Dawley rat plasma at 1 mg/kg, po after 6 hrs | ChEMBL. | 17293118 |
Inhibition (binding) | = 86 % | Ex vivo inhibition of DPP4 in Sprague-Dawley rat plasma at 1 mg/kg, po after 6 hrs | ChEMBL. | 17293118 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.